Digene receives marketing clearance

DIGE received FDA marketing clearance for its Hybrid Capture II Chlamydia/Gonorrhea Test (HCII CT/GT) to detect chlamydia trachomatis DNA and Neisseria gonorrhoeae DNA in cervical specimens. Abbott (A...